Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
|Study ID||Alternative Stable ID||Type|
Study Datasets 2 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Whole genome and Whole exome sequencing of patient-derived xenograft models of endometrial cancer
|HiSeq X Ten,Illumina HiSeq 2500,Illumina HiSeq 4000||50|
SNP Array Data for EGAS00001004666
|Illumina Global Screening Array-24 V1 HTS GSA+Multi-Disease||100|